| Literature DB >> 17252185 |
Ladan Espandar1, Susan O'Brien, Charles Thirkill, Linda A Lubecki, Bita Esmaeli.
Abstract
We herein report a patient with cancer-associated retinopathy who experienced multiple bouts of paraneoplastic retinopathy and optic neuropathy but responded to treatments with alemtuzumab and was able to maintain useful vision over the course of 8 years of follow-up.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17252185 DOI: 10.1007/s11060-006-9326-7
Source DB: PubMed Journal: J Neurooncol ISSN: 0167-594X Impact factor: 4.506